Background: Steroid hormone receptors constitute a special group of receptors having a wide range of effi ciency and distribution in the body. Androgen and estrogen receptors, and their expression in the body, are linked with attributes such as reproduction control and sexual behaviour, but their relation with behavioural models, perception, memory and stress remain unclear to date.
INTRODUCTION
Huntington's Disease (HD) is an inherited, autosomal dominant, neurodegenerative disorder characterized by progressive motor, psychiatric and cognitive symptoms. The principal causative factor is repetition of an expanded trinucleotide CAG in the Huntingtin gene on chromosome 4 (4p16.3). The incidence of HD in the territories of Europe and the Americas is currently estimated at 1:15.000(ref. 1 ). The mutation character was identifi ed in 1993 as a consequence of multiplication of CAG triplet above 39 repetitions. Clinically, HD in its typical form is manifested by the classic clinical triad of: motive, cognitive and psychiatric affl ictions 18 . The set of motive affl ictions comprise typical choreic dyskinesia and disturbance in voluntary movements; whereas cognitive affl ictions are clinically manifested by progressive and advanced dementia of predominantly subcortical type, and psychiatric impairments exhibited in the clinical picture as behavioural changes, hypersexuality, personality disorder, aff ection disorder and more rarely as psychotic phenomena. It is to be borne in mind that cognitive disorders may manifest as early as 5 years prior to the appearance of motive impairments. Among the pathophysiological and degenerative changes of somewhat moderate intensity, the striate spiny neurons have been implicated; such cells are known to induce GABAdescribed degenerative changes in the neocortex. The signifi cance and function of normal as well as mutagenous Huntingtin protein (htt) is currently the subject of intensive study 11, 15, 18 . Our study aims to focus on determining the role of a group of steroid receptors, mainly the estrogen hormone receptors (ER), in Huntington's Disease. ER expression in the brain has a signifi cant infl uence in reproduction control, but the signifi cance of these hormone receptors is also merited in the psychic, behavioural and conduct aspects of an individual. Of the two isoform ER types located on two separate genes -ERα isoform on chromosome 6 (6q25.1) highly expressed in the mammary gland, ovary, liver and ERβ located on chromosome 14 (14q22-24) mainly expressed in the GIT 4, 17 , our study mainly focuses on ERα as the preliminary step in the investigation.
More recent studies refer to the fact that these isoforms can have distinct functional signifi cance in the light of the fact that ERα and β are expressed in many tissues including the CNS (namely in the hypothalamus, hippocampus and the cortex) where the precise location and function in relation to memory, behaviour and conduct remain unclear, or rather more precisely not specifi ed to date. Given the function and broad scope of activities of both ERα and β, inclusive of the fact that they play a signifi cant role in the CNS as mentioned above, we remain confi dent of establishing a defi nite correlation between Huntington's Disease and the estrogen hormone receptors since the latter have an established role in cognition, behaviour and memory 8, 9, 13, 12 . 54
The aim of this long-term study is to focus on monitoring SHR expression in embryonic and adult tissues, namely the CNS, inclusive of monitoring the developmental aspects and the associated normal and aberrant htt; furthermore, to distinguish the pathways of SHR involvement in behavioural, cognitive and memory modifi cations. Our eff ort also extends to studying the mechanisms by which SHR mediates behaviour, cognition and memory, inclusive of the particular segment of the brain where increased and/or decreased SHR expression is exhibited. During the course of the above, we shall also be able to render a comparison of the mediating mechanisms and biological functions of SHR in the brain and its potential relation to Huntington's Disease.
MATERIALS AND METHODS
The fi rst part of the long-term study was divided into the phase of SHR mapping and Huntingtin-associated protein 1 (HAP1) in embryonic as well as adult brain tissue, and further on the construction of plasmid which will be utilised at a later stage for SHR and aberrant Huntintin protein expression.
To map SHR and HAP1 expression in the brain, immuno-histochemistry ABC methods were used in the neocortex in 1:400 dilution and immuno-fl uorescence in 1:600, including RT PCR. For the possibility of increasing or reducing SHR expression, the fi rst phase comprised of plasmid pEGFP-C2-ERα (6499bp) construction; the correctness of which was verifi ed by standard electrophoresis and sequencing. The expression function was verifi ed by transfection in cell line HEK 293, which under normal circumstances does not exprimate isoform ERα. After 48 hours of transfection, ERα expression was verifi ed by immuno-histochemistry on cell line. In order to secure accurate function of pEGFP-C2-ERα, DAPI detection was conducted to ascertain cytoplasmic and/or nuclear activity expressions.
RESULTS

Immuno-histochemistry
Following analysis of the specimen profi les, we ascertained ER expression in the hypothalamic area of mus musculus as control and for positive results the cytoplasmic positive response in areas S1Tr and S1BF, inclusive of positive cytoplasmic and nuclear activity in the SFO region. (Fig. 1a, b) The areas RSA and S2 represented regions where the results were not absolutely and clearly positive. It is to be noted that we approached interpreting these results as positive in a very cautious manner and supplemented our fi ndings by RT from the neocortical areas of RSA, S2 and RSA, S2, which also came out as positive 16 . Another cytoplasmic positive detection was 
RT and PCR
A plasmid pEGFP-C2-ERα was constructed with verifi cation of correct construction and sequencing for mutation detection (Fig. 3) and expression function by immuno-fl uorescence in cell line HEK 293. (Fig. 4 a, b) Following detection of nuclear activity through DAPI, we ascertained nuclear and weak cytoplasmic positivity -marked with arrow. In terms of the current phase of our study, we can state that a plasmid suitable for expression of ER isoform alpha is ready. (Fig. 5 a, b) In the next phase, we will construct a plasmid suitable for ER isoform beta, AR expression and the plasmid for creating a HD mouse model subject to the permission by GMO.
DISCUSSION
Huntington's Disease, as an inherited, autosomal dominant and neurodegenerative disease, owes its clinical picture to a set of conditions caused by increased number of CAG repeats in the huntingtin gene on chromosome 4. Early in the progression of HD, motor changes include mild chorea, abnormal muscle stretch refl exes, and diminished rapid alternating movements. Marshall 15 describes the cognitive manifestations early in the course of the disorder, and they primarily consist of abnormalities in information progression, cognitive fl exibility, and memory retrieval 15, 18 . These neurological symptoms are apparently associated with nuclear accumulation of mutant huntingtin protein and its eff ect on gene expression. Normal huntingtin protein is a cytoplasmic protein and is also associated with synaptic vesicles. Li demonstrated that mutant htt may interact with synaptic vesicle membrane proteins or proteins associated with vesicles in axonal terminals. One of these interacting proteins may be Huntingtin-associated protein1 (HAP1) 3, 11, 20 . Steroid hormone receptors are a special type of receptors because of their localisation in the cytoplasm or nucleus of eukaryotic cells. Recent sensitive binding studies have shown the presence of ER in neocortex cells, where their function remains vague. However, the hypothesis that their involvement in mediation of estrogen infl uence on sexual behaviour 6,10 is gaining strength. The fact that HD presents with a varied clinical picture prompted us to study the pathways and functions of steroid hormone receptors in vitro and mainly on HD model in animal. As we know, HD mouse model was compiled and as stipulated by Li 11 , we know that studies comprising HD mouse models provide compelling evidence to the fact that the N-terminal fragments of mutant Huntingtin protein(htt) with expanded glutamine repeat (82Q or 150Q) "cause neurological symptoms resembling some of the clinical features of HD" 2, 11, 14 . By constructing plasmid pEGFP-C2-ERα and others we would like to utilise the potential cooperation of SHR on HD for the purposes of highlighting the potential and prospective methods of assisting in remedying the behavioural, cognitive and memory defi ciencies found in HD. 
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